サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：免疫組織化学市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1309862

免疫組織化学市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Immunohistochemistry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Product, By Application, By End User, By Region and By Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

免疫組織化学市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の免疫組織化学市場は、予測期間中に目覚ましい成長を遂げると予測されています。

これは、世界中で技術的に高度な免疫組織化学ソリューションの導入とともに、免疫組織化学における自動化と機械学習の導入に対する需要が高まっていることに起因しています。さらに、製品承認の増加や、疾患診断のための技術的に高度なIHCシステムの発売が、予測期間中の市場の成長をさらに促進しています。同様に、製薬業界やバイオテクノロジー業界における研究開発費の増加は、市場の成長を促進する主な要因です。さらに、個別化医療への嗜好の高まり、がんゲノム研究、患者関与要件の増加が、予測期間中の市場の需要を促進すると予想されます。同様に、病理学、神経病理学、血液病理学における抗体の使用量の増加は、予測期間中に免疫組織化学市場の需要をさらに高めると予想されます。2021年8月、FDAは抗PD-1免疫療法の対象となるdMMR固形腫瘍患者を同定するためのRocheのVENTANA MMR RxDx Panelを承認しました。

慢性疾患の有病率の増加

老年人口の増加とともに、がんの有病率が高まっていることは、予測期間中に市場の成長をさらに押し上げると予想される主要因の1つです。2020年7月に発表された合同調査委員会の報告書欧州委員会によると、2020年には欧州連合で約270万人（非黒色腫がんを除く）の新規がん症例が診断され、乳がんが最も多く、2020年には約35万5,000人の新規症例が発生すると推定されています。さらに、慢性腎臓障害の有病率の増加は、予測期間中に有利な成長をもたらすと予想されます。さらに、酵素、腫瘍特異的抗原、腫瘍抑制遺伝子、がん遺伝子、腫瘍細胞増殖マーカーを同定することによる腫瘍の分析需要の高まりは、予測期間中に免疫組織化学市場の需要を高めると予想されます。さらに、心血管疾患、心臓病、喘息、慢性閉塞性肺疾患の罹患率の増加と病院を訪れる患者数の増加が、予測期間中の免疫組織化学市場の需要を高める可能性があります。

個別化医療への需要の高まり

非小細胞肺がん患者に対する個別化医療への需要の高まりは、予測期間中の免疫組織化学の需要を高めました。さらに、この技術は、可能な限り完全で正確な腫瘍の組織学的サブタイピングを行うことにより、適切な治療決定を行うのに役立ちます。同様に、BRAF V600EやIDH1 R132Hのような変異タンパク質を検出できる免疫組織化学アッセイの利用可能性が高まっていることも、予測期間中の市場をさらに牽引するであろう。免疫組織化学検査は、分子生物学的検査の代替または補助として有用です。これらの技術は再現性が高く、技術的な複雑さや解釈の複雑さを伴わず、より安価に入手できます。多重免疫組織化学アッセイや変異特異的免疫組織化学アッセイの市場開拓は重要な技術革新であり、予測期間中の市場成長をさらに促進すると期待されています。2020年7月にLaboratory Investigation誌に掲載された調査によると、COVID-19感染の検出には免疫組織化学（IHC）アッセイとin situハイブリダイゼーション（ISH）アッセイが利用されました。

利用可能なカスタマイズ

TechSci Researchでは、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 調査対象年
    • 主要市場セグメンテーション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 免疫組織化学の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 地域別
    • 企業別
  • 市場マップ
    • 製品別
    • 用途別
    • エンドユーザー別
    • 地域別

第6章 北米の免疫組織化学市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の免疫組織化学市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の免疫組織化学市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の免疫組織化学市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの免疫組織化学市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品発表

第13章 免疫組織化学の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • F.Hoffmann-La Roche Ltd.
    • Merck KGaA.
    • Danaher Corporation.
    • Perkinelmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology Inc.
    • Bio SB.
    • Agilent Technologies, Inc.
    • Abcam Plc.

第16章 戦略的提言

目次
Product Code: 14820

Global Immunohistochemistry market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for the implementation of automation and machine learning in immunohistochemistry, along with the introduction of technologically advanced immunohistochemistry solutions across the globe. Moreover, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further driving the growth of the market during the forecast period. Similarly, growing research and development expenditures in the pharmaceutical and biotechnology industries are the major factors driving the growth of the market. Moreover, growing preference for personalized medicine, cancer genomics studies, and increasing patient engagement requirements is expected to drive the demand for the market during the forecast period. Similarly, the growing usage of antibodies in pathology, neuropathology, and hematopathology is expected to further enhance the demand for the immunohistochemistry market during the forecast period. In August 2021, the FDA approved Roche's VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy.

Growing Prevalence of Chronic Diseases

The growing prevalence of cancer, along with the increasing geriatric population, is one of the major factors which is expected to further boost the growth of the market during the forecast period. As per the Joint Research Commission's report European Commission released in July 2020, it was estimated that in 2020 about 2.7 million (excluding non-melanoma cancer) new cancer cases would be diagnosed in the European Union, and breast cancer will be the most prevalent form of cancer with about 355,000 new cases in 2020. Moreover, the growing prevalence of chronic kidney disorders is expected to create lucrative growth during the forecast period. Furthermore, growing demand for analyzing tumors by identification of enzymes, tumor-specific antigens, tumor suppressor genes, oncogenes, and tumor cell proliferation markers is expected to enhance demand for the immunohistochemistry market during the forecast period. Moreover, the growing incidence of cardiovascular diseases, heart diseases, asthma, and chronic obstructive pulmonary diseases, along with the rising number of patient visits to hospitals, can enhance the demand for the immunohistochemistry market during the forecast period.

Growing Demand for Personalized Medicine

The growing demand for personalized medicine for non-small cell lung cancer patients enhanced the demand for immunohistochemistry during the forecast period. Moreover, this technique helps in making appropriate treatment decisions by performing the most complete and accurate histological subtyping of tumors possible, which can enhance the demand for the market over the years. Similarly, the growing availability of immunohistochemistry assays that can detect mutant proteins such as BRAF V600E and IDH1 R132H will further drive the market during the forecast period. It can provide a helpful replacement or adjunct for molecular testing. These techniques are highly reproducible, entail reasonable technical and interpretation complexity, and are also available at lesser costs. The growing development of multiplex and mutation-specific immunohistochemistry assays represents important innovations that are expected to further drive the growth of the market during the forecast period. According to research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting COVID-19 infection.

Market Segmentation

Global Immunohistochemistry market can be segmented on the basis of product, application, end-user, and by region. Based on the product, the market can be segmented into antibodies, equipment, reagents, and kits. On the basis of application, the market can be segmented into diagnostics, drug testing, and forensic applications. Based on end-user, the market can be further divided into hospitals & diagnostic laboratories, research institutes, and others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global immunohistochemistry market on account of the growing prevalence of chronic diseases in the country.

Recent Developments

  • In June 2022, Roche launched HPV self-sampling solution and expanded cervical cancer screening options.
  • In February 2022, Moderna and Thermo Fisher Scientific announced a long-term strategic collaboration for manufacturing of Spikevax vaccine in the U.S. for diagnosis of COVID-19 and other investigational mRNA medicines in this pipeline.
  • In February 2022, a new genetic analyzer brought advanced capabilities to sanger sequencing and fragment analysis, which is called capillary electrophoresis, and it enables sanger sequencing and fragment analysis, which is essential for improving clinical research and advancing scientific discovery.

Market Players

Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., Merck KGaA., Danaher Corporation., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology Inc., Bio SB., Agilent Technologies, Inc. are some of the leading players operating in the global Immunohistochemistry market.

Report Scope

In this report, global Immunohistochemistry market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Immunohistochemistry Market, By Product:

  • Antibodies
  • Equipment
  • Reagents
  • Kits

Immunohistochemistry Market, By Application:

  • Diagnostics
  • Drug Testing
  • Forensic applications

Immunohistochemistry Market, By End User:

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

Immunohistochemistry Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunohistochemistry Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunohistochemistry Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 5.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 5.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product
    • 5.3.2 By Application
    • 5.3.3 By End User
    • 5.3.4 By Region

6. North America Immunohistochemistry Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 6.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 6.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Immunohistochemistry Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Immunohistochemistry Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Immunohistochemistry Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Immunohistochemistry Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 7.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 7.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Immunohistochemistry Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Immunohistochemistry Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Immunohistochemistry Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Immunohistochemistry Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Immunohistochemistry Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Immunohistochemistry Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 8.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 8.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Immunohistochemistry Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Immunohistochemistry Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Immunohistochemistry Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Immunohistochemistry Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Immunohistochemistry Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Immunohistochemistry Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 9.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 9.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Immunohistochemistry Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Immunohistochemistry Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Immunohistochemistry Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Immunohistochemistry Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 10.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 10.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Immunohistochemistry Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Immunohistochemistry Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Immunohistochemistry Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Immunohistochemistry Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Thermo Fisher Scientific Inc.
    • 15.6.2 F.Hoffmann-La Roche Ltd.
    • 15.6.3 Merck KGaA.
    • 15.6.4 Danaher Corporation.
    • 15.6.5 Perkinelmer, Inc.
    • 15.6.6 Bio-Rad Laboratories, Inc.
    • 15.6.7 Cell Signaling Technology Inc.
    • 15.6.8 Bio SB.
    • 15.6.9 Agilent Technologies, Inc.
    • 15.6.10 Abcam Plc.

16. Strategic Recommendations